Regulation of B cell homeostasis and activation by the tumor suppressor gene CYLD
Open Access
- 8 October 2007
- journal article
- Published by Rockefeller University Press in The Journal of Experimental Medicine
- Vol. 204 (11), 2615-2627
- https://doi.org/10.1084/jem.20070318
Abstract
B cell homeostasis is regulated by multiple signaling processes, including nuclear factor-κB (NF-κB), BAFF-, and B cell receptor signaling. Conditional disruption of genes involved in these pathways has shed light on the mechanisms governing signaling from the cell surface to the nucleus. We describe a novel mouse strain that expresses solely and excessively a naturally occurring splice variant of CYLD (CYLDex7/8 mice), which is a deubiquitinating enzyme that is integral to NF-κB signaling. This shorter CYLD protein lacks the TRAF2 and NEMO binding sites present in full-length CYLD. A dramatic expansion of mature B lymphocyte populations in all peripheral lymphoid organs occurs in this strain. The B lymphocytes themselves exhibit prolonged survival and manifest a variety of signaling disarrangements that do not occur in mice with a complete deletion of CYLD. Although both the full-length and the mutant CYLD are able to interact with Bcl-3, a predominant nuclear accumulation of Bcl-3 occurs in the CYLD mutant B cells. More dramatic, however, is the accumulation of the NF-κB proteins p100 and RelB in CYLDex7/8 B cells, which, presumably in combination with nuclear Bcl-3, results in increased levels of Bcl-2 expression. These findings suggest that CYLD can both positively and negatively regulate signal transduction and homeostasis of B cells in vivo, depending on the expression of CYLD splice variants.This publication has 34 references indexed in Scilit:
- Specificity of TRAF3 in Its Negative Regulation of the Noncanonical NF-κB PathwayPublished by Elsevier BV ,2007
- Cyld Inhibits Tumor Cell Proliferation by Blocking Bcl-3-Dependent NF-κB SignalingCell, 2006
- Regulation of the Deubiquitinating Enzyme CYLD by IκB Kinase Gamma-Dependent PhosphorylationMolecular and Cellular Biology, 2005
- TRAF2 Differentially Regulates the Canonical and Noncanonical Pathways of NF-κB Activation in Mature B CellsImmunity, 2004
- NF-κB2/p100 induces Bcl-2 expressionLeukemia, 2003
- NF-κB activation in cancer: a challenge for ubiquitination- and proteasome-based therapeutic approachSeminars in Cancer Biology, 2003
- Activation of the IκB Kinase Complex by TRAF6 Requires a Dimeric Ubiquitin-Conjugating Enzyme Complex and a Unique Polyubiquitin ChainCell, 2000
- Linkage and LOH studies in 19 cylindromatosis families show no evidence of genetic heterogeneity and refine the CYLD locus on chromosome 16q12-q13Human Genetics, 2000
- A new hereditary cylindromatosis family associated with CYLD1 on chromosome 16Human Genetics, 1999
- Familial cylindromatosis mimicking tuberous sclerosis complex and confirmation of the cylindromatosis locus, CYLD1, in a large family.Journal of Medical Genetics, 1998